Ciclesonide
Ciclesonide
Definition
A nonhalogenated, synthetic, inhaled corticosteroid (ICS) with anti-inflammatory and potential antiviral activities. Upon administration by oral inhalation into the lungs, ciclesonide (CIC) is converted by local esterases to its active metabolite desisobutyryl-ciclesonide (des-CIC), which binds to intracellular glucocorticoid receptors (GRs). The ligand-bound GRs regulate gene expressions, which lead to inhibitory activities against multiple cell types, such as mast cells, eosinophils, basophils, lymphocytes, macrophages and neutrophils, and various mediators associated with inflammation, such as histamine, eicosanoids, leukotrienes and cytokines. In addition, ciclesonide may suppress the replication of human coronavirus by targeting viral nonstructural protein 15 (NSP15).
Also known as Alvesco, CICLESONIDE, Omnaris — per NCIT
Also identified as
- ATC R01AD13 per RXNORM
- ATC R03BA08 per RXNORM
- NCIT NCIT:C65326 per NCIT
- SCTID 416739001 per RXNORM
- SCTID 417420004 per RXNORM
- UNII S59502J185 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Perennial allergic rhinitis | may treat | MEDRT · Public domain (U.S. Government work) |
| Seasonal allergic rhinitis | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Craniocervical region | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Nasal cavity | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.